Harmony - M&A Summary and Business Overview

Life ScienceCompany

Harmony M&A Summary

Harmony has acquired 2 companies, including 2 in the last 5 years.

Harmony’s largest acquisition to date was in 2023, when it acquired Zynerba Pharmaceuticals for $200M. Harmony has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).

Harmony Business Overview

Where is Harmony headquartered?

Harmony is headquartered in Plymouth Meeting, Pennsylvania.

What is Harmony’s revenue?

Harmony disclosed revenue of 582M USD for 2023 and 438M USD for 2022.

How many employees does Harmony have?

Harmony has 246 employees.

What sector is Harmony in?

Harmony is a life science company.

When was Harmony founded?

Harmony was founded in 2017.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Advisors 1

Harmony

Harmony Biosciences LLC

630 W. Germantown Pike, Suite 215,
Plymouth Meeting, Pennsylvania 19462
United States,
(484) 539-9800
www.harmonybiosciences.com

Harmony is a biopharmaceutical company developing and commercializing innovative drugs to address unmet needs for patients with sleep and CNS disorders. Harmony was founded in 2017 and is based in Plymouth Meeting, Pennsylvania.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.4/yr) # - - - - 1 1 2
vol $200M $200M
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Epygenix Therapeutics, Inc. 2024-04-30 - Add-on Acquisition
Paramus, New Jersey · www.epygenix.com
Zynerba Pharmaceuticals, Inc. 2023-08-14 200M USD Add-on Acquisition
Devon, Pennsylvania · www.zynerba.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) 200M (100%) - -
Total 2 $200M - -

By Geo

State/Country Buy Value Sell Value
United States 2 200M - -
  Pennsylvania 1 200M - -
  New Jersey 1 - - -
Total 2 $200M - -

Top M&A Advisors

Legal Deals
Hogan Lovells
1

Deal Values

buy # Total
$100M to $1B 1 $200M
TOTAL $200M
Largest Zynerba Pharmaceuticals, Inc.
$200M (2023-08-14)

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.